Carfilzomib for the Prevention of Graft Versus Host Disease

Update Il y a 5 ans
Reference: NCT01991301

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The aim of this study is to evaluate the safety and efficacy of Carfilzumib, which is a novel biological agent used in the treatment of multiple myeloma in preventing graft-versus-host disease, after stem cells transplantation from unrelated donors.


Inclusion criteria

  • Graft-versus-host disease

Links